AXGN (Axogen) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AXGN Axogen Inc AXGN
64 GF Score
Price $40.26
GF Value $15.30
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Axogen Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

AXGN
64GF Score
Axogen Inc AXGN
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Axogen (AXGN) Overvalued in 2026?

Based on GuruFocus' analysis, Axogen stock appears to be overvalued. The current stock price of $40.26 is trading 163.1% above its estimated GF Value™ of $15.30. GuruFocus considers Axogen to be Significantly Overvalued.

Key valuation signals for AXGN:

  • Short Ratio:
  • GF Value™: $15.30 vs. price of $40.26 (163.1% above fair value)
  • GF Score™: 64/100 with 2 warning signs

No single metric tells the full story. See the AXGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Axogen Business Description

Other Exchanges 0HKD:UKLT3:Germany
Address 13631 Progress Boulevard, Suite 400, Alachua, FL, USA, 32615
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
64GF Score

Get the complete analysis for AXGN

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$40.26
Price
$15.30
GF Value